TSE:NVCN Neovasc (NVCN) Stock Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day RangeC$40.15▼C$40.1552-Week Range N/AVolume399 shsAverage Volume2,123 shsMarket CapitalizationC$110.81 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Neovasc alerts: Email Address Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. About Neovasc Stock (TSE:NVCN)Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.Read More Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. NVCN Stock News HeadlinesFebruary 14, 2024 | investing.comAptose Biosciences Inc (APS)April 6, 2023 | theglobeandmail.comClosing Bell: Neovasc Inc up on Thursday (NVCN)July 27, 2024 | Porter & Company (Ad)Nvidia insiders dumping sharesAll the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.February 1, 2023 | theglobeandmail.comNeovasc: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (NVCN)January 17, 2023 | finance.yahoo.comShockwave Medical to Acquire NeovascJanuary 17, 2023 | marketwatch.comShockwave Medical to Buy Neovasc for $75 MillionJanuary 17, 2023 | benzinga.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Neovasc Inc. (NVCN)November 11, 2022 | seekingalpha.comNeovasc Inc. (NVCN) Q3 2022 Earnings Call TranscriptJuly 27, 2024 | Porter & Company (Ad)Nvidia insiders dumping sharesAll the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.November 8, 2022 | finance.yahoo.comNeovasc Reducer Obtains U.S. Outpatient ReimbursementOctober 30, 2022 | finance.yahoo.comNeovasc Inc. (NVCN)September 20, 2022 | finance.yahoo.comNeovasc Provides Corporate Update Following Clinical Data ReleaseSeptember 16, 2022 | finance.yahoo.comNeovasc to Participate in LSI Europe 2022 Emerging MedTech SummitSeptember 15, 2022 | reuters.comNVCN.TO - Neovasc Inc | Stock Price & Latest News | ReutersAugust 30, 2022 | finance.yahoo.comNeovasc to Participate in H.C. Wainwright 24th Annual Global Investment ConferenceAugust 11, 2022 | seekingalpha.comNeovasc Inc. (NVCN) CEO Fred Colen on Q2 2022 Results - Earnings Call TranscriptJuly 28, 2022 | finance.yahoo.comNeovasc to Report Second Quarter Financial Results on August 11, 2022July 26, 2022 | marketwatch.comNeovasc Says FDA Approves Protocol Supplement for Angina StudySee More Headlines Receive NVCN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Neovasc and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeTSE SectorManufacturing Industry Surgical & Medical Instrument Manufacturing Sub-IndustryN/A Current SymbolTSE:NVCN CUSIPN/A CIKN/A Webwww.neovasc.com Phone16042704344FaxN/AEmployees49Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($20.44) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-33,520,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-78.25% Return on Assets-32.95% Debt Debt-to-Equity Ratio44.86 Current Ratio8.44 Quick Ratio8.04 Sales & Book Value Annual SalesC$3.11 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow1.05 Book ValueC$10.22 per share Price / BookN/AMiscellaneous Outstanding Shares2,760,000Free FloatN/AMarket CapC$110.81 million OptionableNot Optionable Beta2.01 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Fredericus A. Colen (Age 71)Pres, CEO & Director Comp: $2.59MMr. Christopher Clark B.A. (Age 51)BA (Honours), C.A., CA, PgD, CFO & Corp. Sec. Comp: $1.42MMr. William Reed Little (Age 52)Chief Operating Officer Comp: $1.2MMr. John Christopher Panton (Age 56)Chief Quality Officer Comp: $505.88kSarah Marie-Hodgson GallagherVP of Clinical AffairsKey CompetitorsSTERIS’TSE:STEHardwoods DistributionTSE:HWDIntegra GoldCVE:ICGVBI VaccinesTSE:VBVChemtrade Electrochem Inc,TSE:CUSView All Competitors NVCN Stock Analysis - Frequently Asked Questions How do I buy shares of Neovasc? Shares of NVCN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:NVCN) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neovasc Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neovasc With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
